If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,178.00
Bid: 1,178.00
Ask: 1,182.00
Change: 14.00 (1.20%)
Spread: 4.00 (0.34%)
Open: 1,158.00
High: 1,196.00
Low: 1,158.00
Prev. Close: 1,164.00
SVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

26 May 2022 15:56

RNS Number : 9801M
Savills PLC
26 May 2022
 

SAVILLS PLC (THE "COMPANY")

TRANSACTION IN SHARES BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)

 

Vesting of Share Awards

 

On 26 May 2022, ordinary shares of the Company have been allotted to Directors and PDMRs of the Company as follows in satisfaction of the partial vesting of Awards made on 22 May 2017 under the Performance Share Plan:-

 

Director / PDMR

Number of Shares Transferred

Number of Shares Disposed

Shareholding following this notification

Shareholding as a % of issued share capital

Beneficial interest under the Performance Share Plan following this notification

Mark Ridley (Director)

26,830

26,830

231,854

0.16

242,453

Simon Shaw (Director)

26,830

26,830

182,579

0.13

188,176

Chris Lee (PDMR)

7,985

7,985

119,000

0.08

95,690

 

The share price on disposal of all shares was £10.952661 per share.

 

The balance of the Awards made on 22 May 2017 have lapsed.

 

On 25 May 2022 the grant of an award has been made under The Schedule to The Savills Deferred Share Plan to a PDMR based in the United States of America as follows:-

 

PDMR

Number of shares subject to the Savills Deferred Share Plan awarded to the PDMR on 25 May 2022

Resulting beneficial interest under the Savills Deferred Share Plan

David Lipson

25,847

127,017

 

20% of the above award will vest on 18 April 2023, being the anniversary of the programme's original inception, and then 20% on each of the subsequent four anniversaries of that date subject to continued employment and satisfaction of performance criteria relating to gross billings.

 

The award is subject to rolled-up dividend shares whereby the number of shares awarded shall be increased on the vesting dates to reflect final and interim dividends declared during the Deferred Periods.

 

 

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the Director/ PDMR

 

(a)

Name

1. Mark Ridley

2. Simon Shaw

3. Chris Lee

4. David Lipson

 

2.

Reason for the notification

 

(a)

Position/ status

1. Group Chief Executive/ Director

2. Group Chief Financial Officer/ Director

3. Group Legal Director and Company Secretary/ PDMR

4. President - Savills North America/ PDMR

 

(b)

Initial notification/ Amendment

 

Initial notification

3.

Details of the issuer

 

(a)

Name

Savills plc

 

(b)

LEI

213800WXICGMBWHTA933

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Vesting of awards under the Company's Performance Share Plan and sale of resultant shares for persons 1 - 3

 

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

Acquisition

£0.025 per share

 

1. 26,830

2. 26,830

3. 7,985

 

Disposal

£10.952661 per share

1. 26,830

2. 26,830

3. 7,985

 

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

26 May 2022

(g)

Place of the transaction

 

London Stock Exchange (XLON)

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

Award over Savills plc Ordinary Shares in accordance with the Company's Deferred Share Plan

 

(b)

Identification code of the Financial instrument

GB00B135BJ46

(c)

Nature of the transaction

Grant of an award over Ordinary Shares in accordance with the Company's Deferred Share Plan in respect of David Lipson

 

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

£nil per share

25,847

(d)

Aggregated information

 

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

25 May 2022

(g)

Place of the transaction

Outside a trading venue

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

26 May 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGZKDVKGZZM
Date   Source Headline
2nd May 20248:28 amRNSTotal Voting Rights
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results
13th Mar 20241:37 pmRNSDirector/PDMR Shareholding
15th Feb 202410:00 amRNSBlock listing Interim Review
13th Feb 20246:07 pmRNSDirector/PDMR Shareholding
1st Feb 202411:00 amRNSTotal Voting Rights
22nd Jan 20249:11 amRNSBlock listing Interim Review
11th Jan 20244:02 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNSYear End Trading Update
2nd Jan 202412:33 pmRNSTotal Voting Rights
15th Dec 202310:00 amRNSAdditional Listing
14th Dec 202312:56 pmRNSDirector/PDMR Shareholding
13th Dec 202311:42 amRNSNon-Executive Director Appointment
13th Nov 20232:02 pmRNSSAVILLS APPOINTS NEW CEO OF SAVILLS NORTH AMERICA
13th Nov 202312:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20233:16 pmRNSForm 8.3 - OntheMarket PLC
1st Nov 202310:00 amRNSTotal Voting Rights
27th Oct 202310:00 amRNSAdditional Listing
12th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20238:50 amRNSTotal Voting Rights
22nd Sep 202311:00 amRNSAdditional Listing
12th Sep 20235:10 pmRNSTotal Voting Rights
1st Sep 202311:00 amRNSTotal Voting Rights
18th Aug 20232:00 pmRNSAdditional Listing
15th Aug 20234:06 pmRNSBlock listing Interim Review
14th Aug 20232:05 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSChair Succession
10th Aug 20237:00 amRNSHalf-year Report
21st Jul 202310:00 amRNSBlock listing Interim Review
11th Jul 202312:50 pmRNSDirector/PDMR Shareholding
4th Jul 20239:20 amRNSTotal Voting Rights
13th Jun 20235:31 pmRNSDirector/PDMR Shareholding
1st Jun 202310:00 amRNSTotal Voting Rights
17th May 20234:05 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Statement
11th May 20236:12 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20235:15 pmRNSDirector/PDMR Shareholding
12th Apr 20232:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:15 pmRNSAnnual Report and AGM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.